Quick Answer
ProPhase Labs, Inc. reported Stockholders Equity of $7.35 million for the year ending 2024.
- ProPhase Labs, Inc. showed a decrease of -85.1% in Stockholders Equity from 2023 to 2024.
- This data is from ProPhase Labs, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
- XBRL data for this metric is available from 2008 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $9.89 million | Q1 2013: $11.98 million | Q2 2013: $10.30 million | Q3 2013: $11.63 million | Q1 2014: $12.80 million | Q2 2014: $13.61 million | Q3 2014: $10.54 million | Q1 2015: $9.37 million | Q2 2015: $8.36 million | Q3 2015: $10.04 million | Q1 2016: $7.49 million | Q2 2016: $6.37 million | Q3 2016: $6.53 million | Q1 2017: $50.67 million | Q2 2017: $46.63 million | Q3 2017: $36.65 million | Q1 2018: $31.88 million | Q2 2018: $20.53 million | Q3 2018: $19.70 million | Q1 2019: $15.70 million | Q2 2019: $14.65 million | Q3 2019: $14.40 million | Q1 2020: $10.63 million | Q2 2020: $10.89 million | Q3 2020: $10.76 million | Q1 2021: $52.67 million | Q2 2021: $47.73 million | Q3 2021: $48.26 million | Q1 2022: $66.45 million | Q2 2022: $68.16 million | Q3 2022: $67.92 million | Q1 2023: $59.94 million | Q2 2023: $59.26 million | Q3 2023: $56.43 million | Q4 2023: $49.38 million | Q1 2024: $44.87 million | Q2 2024: $44.08 million | Q3 2024: $38.13 million | Q4 2024: $7.35 million | Q1 2025: $15.12 million | Q2 2025: $11.44 million | Q3 2025: $6.86 million.
- Over the full 17 years of available data (2008 to 2024), ProPhase Labs, Inc.'s Stockholders Equity has declined by 58.6%.
- Historical annual values: Fiscal year 2024: $7.35 million | Fiscal year 2023: $49.38 million | Fiscal year 2022: $63.63 million | Fiscal year 2021: $58.63 million | Fiscal year 2020: $10.56 million | Fiscal year 2019: $11.23 million | Fiscal year 2018: $16.50 million | Fiscal year 2017: $31.85 million | Fiscal year 2016: $5.96 million | Fiscal year 2015: $8.83 million | Fiscal year 2014: $10.72 million | Fiscal year 2013: $12.60 million | Fiscal year 2012: $11.45 million | Fiscal year 2011: $11.23 million | Fiscal year 2010: $13.46 million | Fiscal year 2009: $14.06 million | Fiscal year 2008: $17.77 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: